Skip to main content

ORIGINAL ARTICLE

Int J Public Health, 30 May 2024
This article is part of the Special Issue SCIENCE TO FOSTER THE WHO AIR QUALITY GUIDELINE VALUES View all 7 articles

Health and Economic Benefits of Complying With the World Health Organization Air Quality Guidelines for Particulate Matter in Nine Major Latin American Cities

Lina Madaniyazi
&#x;Lina Madaniyazi1*Jefferson Alpízar&#x;Jefferson Alpízar1Luis Abdn CifuentesLuis Abdón Cifuentes2Horacio Riojas-RodríguezHoracio Riojas-Rodríguez3Magali Hurtado DíazMagali Hurtado Díaz3Micheline de Sousa Zanotti Stagliorio CoelhoMicheline de Sousa Zanotti Stagliorio Coelho4Rosana AbrutzkyRosana Abrutzky5Samuel OsorioSamuel Osorio3Gabriel Carrasco EscobarGabriel Carrasco Escobar6Nicols Valds OrtegaNicolás Valdés Ortega2Valentina ColistroValentina Colistro7Dominic Roye&#x;Dominic Roye8Aurelio TobíasAurelio Tobías9
  • 1School of Tropical Medicine and Global Health, Nagasaki University, Nagasaki, Japan
  • 2Departamento de Ingeniería, Pontificia Universidad Católica de Chile, Santiago, Chile
  • 3National Institute of Public Health (Mexico), Cuernavaca, Mexico
  • 4Urban Health Laboratory University of São Paulo, Faculty of Medicine, São Paulo, Rio Grande do Sul, Brazil
  • 5Universidad de Buenos Aires, Facultad de Ciencias Sociales, Instituto de Investigaciones Gino Germani, Buenos Aires, Argentina
  • 6Health Innovation Laboratory, Institute of Tropical Medicine “Alexander von Humboldt”, Universidad Peruana Cayetano Heredia, Lima, Peru
  • 7Department of Quantitative Methods, School of Medicine, University of the Republic, Montevideo, Uruguay
  • 8CIBER de Epidemiología y Salud Pública (CIBERESP), Madrid, Spain
  • 9Institute of Environmental Assessment and Water Research, Spanish National Research Council (CSIC), Barcelona, Spain

Objectives: This study aims to estimate the short-term preventable mortality and associated economic costs of complying with the World Health Organization (WHO) air quality guidelines (AQGs) limit values for PM10 and PM2.5 in nine major Latin American cities.

Methods: We estimated city-specific PM-mortality associations using time-series regression models and calculated the attributable mortality fraction. Next, we used the value of statistical life to calculate the economic benefits of complying with the WHO AQGs limit values.

Results: In most cities, PM concentrations exceeded the WHO AQGs limit values more than 90% of the days. PM10 was found to be associated with an average excess mortality of 1.88% with concentrations above WHO AQGs limit values, while for PM2.5 it was 1.05%. The associated annual economic costs varied widely, between US$ 19.5 million to 3,386.9 million for PM10, and US$ 196.3 million to 2,209.6 million for PM2.5.

Conclusion: Our findings suggest that there is an urgent need for policymakers to develop interventions to achieve sustainable air quality improvements in Latin America. Complying with the WHO AQGs limit values for PM10 and PM2.5 in Latin American cities would substantially benefits for urban populations.

Introduction

In recent decades, Latin American urban centers have witnessed rapid urbanization and industrialization, leading to a surge in air pollution levels [1]. Among the various pollutants, particulate matter (PM) has emerged as a critical public health concern, given its harmful impact on respiratory and cardiovascular systems [24]. The World Health Organization (WHO) has established air quality guidelines (AQGs) for particulate matter (PM), aiming to safeguard human health and well-being [5]. In particular, the WHO AQGs recently updated the annual limit values for particulate matter with an aerodynamic diameter of 10 μm or less (PM10) to 15 μg/m3, and for particulate matter with an aerodynamic diameter of 2.5 μm or less (PM2.5) to 5 μg/m3. However, compliance with these stringent standards remains a significant challenge for major Latin American cities, where factors such as population density, traffic congestion, industrial emissions, and limited resources for environmental management converge.

Understanding the multifaceted implications of non-compliance with WHO AQGs is essential for designing effective mitigation strategies [6]. One crucial aspect of this assessment is the short-term preventable mortality associated with elevated PM levels, especially in Latin American urban centers. While the total burden attributed to long-term exposure far exceeds that of short-term exposure, the immediacy of the latter presents a distinct contrast. Unlike the gradual realization of benefits associated with improved air quality over months and years due to long-term exposure, short-term effects can be mitigated “immediately.” Consequently, policies targeting the reduction of daily concentrations will promptly yield benefits in terms of short-term effects, whereas the broader advantages of enhanced air quality will materialize only over an extended and less precisely defined period. Moreover, the economic ramifications of failing to comply with WHO AQGs demand rigorous investigation. The cost burden extends across various sectors, including healthcare expenditures, loss of labor productivity, and diminished quality of life [7]. By quantifying the economic burden of air pollution, policymakers can make informed decisions regarding resource allocation and prioritize interventions to achieve sustainable air quality improvements.

This study aims to present a comprehensive analysis of short-term preventable mortality and associated economic costs of complying with the WHO AQGs for PM10 and PM2.5 in nine major Latin American cities. These health and economic consequences of PM pollution offer a foundation for evidence-based policy formulation to enhance air quality and preserve the wellbeing of urban populations in Latin America.

Methods

Data Collection

We collected daily time series data on environment and health from nine capital cities or the most populated cities in Central and South American countries (Figure 1), namely, Bogota in Colombia, Buenos Aires in Argentina, Guatemala City in Guatemala, Lima in Peru, Mexico City in Mexico, Montevideo in Uruguay, Quito in Ecuador, Santiago in Chile, and Sao Paulo in Brazil. The dataset covers an overlapping period from 2009 to 2018. Mortality data were obtained from local authorities within each country, represented by daily counts of deaths due to non-external causes (International Classification of Diseases, 9th revision (ICD-9) codes 0 to 799 and ICD-10 codes A0 to R99). In cases where non-external mortality data were unavailable, we collected daily counts of deaths from all causes. We obtained daily concentrations of PM10 in nine cities, and on PM2.5 from five of these cities. Data on both pollutants were available in Mexico City, Montevideo, Quito, Santiago, and Sao Paulo. We also collected data on the daily mean temperature for each city. Data on PM and temperature were all collected from local monitoring stations and networks in each city.

Figure 1
www.frontiersin.org

Figure 1. Geographical location of the cities in the study (Latin America, 2009–2018). Note: PM10: Particulate matter with an aerodynamic diameter of 10 μm or less. PM2.5: Particulate matter with an aerodynamic diameter of 2.5 μm or less.

Statistical Analysis

The analysis included three steps. First, we estimated the PM-mortality association, and then derived the health impact. Finally, we calculated the economic benefits of complying with WHO AQGs limit values for PM concentrations. The analysis was conducted for PM10 and PM2.5 separately using R (version 4.3.1; R Development Core Team).

PM-Mortality Association

We performed city-specific time-series analyses using generalized linear models with quasi-Poisson family [8]. We developed the model based on a previous study [9]. The regression model included a natural cubic spline function with 7 degrees of freedom (df) per year to control for the long-term trends and seasonality and an indicator for the day of the week to account for within-week variation. We used a natural cubic spline function with 6 df for the 4-day moving average of daily mean temperature to account for its confounding effect on PM-mortality associations. We assumed a linear exposure-response association of mortality with PM. To identify the optimal lag days (i.e., the number of days the effect of PM could persist), we used distributed linear models with a natural cubic spline with 3 df for the lag-response association for the same day (lag 0) to four days after the exposure (lag 4). Then we pooled the city-specific estimates for the association by using a random-effects meta-analysis by considering city as a random effect. We reported relative risk (RR) of mortality, and the related 95% confidence interval (95%CI), for a 10 μg/m3 increase of PM10 and PM2.5.

Attributable Mortality

Although we focus on the short-term association between PM and mortality, we utilized the WHO AQGs annual limit value rather than the daily limit value to estimate the attributable mortality. The 2021 WHO AQGs were specifically determined to ensure compliance with the more crucial long-term limit values and the regulations governing daily levels [5]. Essentially, areas that meet the annual AQG limit value are likely also to meet the requirement of not surpassing the daily limit values more than three times a year and vice versa [10]. Therefore, any impact assessment must recognize this consistency: if every day of the year, on average, adheres to the long-term limit value, both the long-term and the short-term AQG values will be met; conversely, if every day was, on average, aligns with the short-term daily mean limit values, the AQG annual mean limits would be significantly violated. Hence, the only appropriate reference values to derive the burden for “non-compliance” with WHO AQGs are the long-term mean limit values (5 and 15 μg/m3, respectively for PM2.5 and PM10), not the short-term limit values [10].

We calculated the attributable mortality associated with the short-term exposure to PM10 and PM2.5 in each city for days above the WHO AQGs annual limit values as 1expβixitc+×dit. Here, βi is the log-RR for a unit increase in PM concentration in city i, xit represents the daily PM concentration in city i on day t, c is the WHO AQGs limit value (c=15μ/m3 for PM10, and c=5μ/m3 for PM2.5), and dit is the daily deaths in city i on day t. Finally, we computed the mortality fraction (%) by summing of the city-specific daily attributable deaths and dividing by the total mortality in each city, allowing for the comparison across cities, jointly with the 95% empirical CIs (eCIs) [11].

Economic Cost

We employed the concept of the value of a statistical life (VSL) to calculate the economic benefits associated with the reduction of PM10 and PM2.5 levels in each city. The VSL serves as a widely used measure in cost-benefit analyses, assessing the health cost related to both environment and healthcare programs that influence social wellbeing, such as the health cost of deaths attributable to PM pollution. Essentially, VSL represents an individual’s willingness to pay to reduce a unit of mortality risk [12]. To quantify the economic benefits of PM reduction, we multiplied the VSL by the number of attributable deaths in each city and calculated the average cost per year.

Ideally, the VSL obtained from the local empirical studies should be used for the calculation. However, such information was not available for the current study. Therefore, to ensure comparability between countries, we relied on international income-adjusted estimates of the country specific VSL [12] as a proxy for the economic cost in each city. The city-specific estimates were reported as annual average number of excess deaths and annual average economic benefits, allowing for a proper comparison between cities with different lengths of study period.

Results

The analysis included 2,582,439 deaths across nine major cities in Latin America, with the period ranging from three to ten years. Table 1 shows the descriptive summary of PM10 and PM2.5 concentrations, average temperature, and daily mortality in each city. On average, the annual mean concentrations of PM10 ranged from 27.4 μg/m3 in Montevideo to 77.9 μg/m3 in Lima, while PM2.5 concentrations ranged from 8.6 μg/m3 in Montevideo to 27.4 μg/m3 in Santiago. Across the cities and study periods, 97.4% and 97.0% of days showed concentrations of PM10 and PM2.5 above the WHO AQGs daily limit values of 15 μg/m3 and 5 μg/m3, respectively. Majority of the days (>90%) in most cities recorded concentrations of PM higher than the WHO AQGs limit values, except for PM2.5 in Montevideo (Supplementary Figure S1).

Table 1
www.frontiersin.org

Table 1. Descriptive summary by city (Latin America, 2009–2018).

The lag-response association for most of the cities suggested a consistent delayed effect of PM on the current day (lag 0) and 1 day before (lag 1) (Supplementary Figures S2–S3). Therefore, we fitted a linear exposure-response association of mortality with the 2-day moving average of daily concentration of PM (lag 0–1 day) and observed a positive association between PM and mortality in all cities (Supplementary Figures S4–S5).

The pooled estimate showed that an increase of 10 μg/m3 in PM10 was associated with a RR of 1.007 (95%CI= [1.004, 1.010]), while PM2.5 was associated with a RR of 1.010 (95%CI= [1.007%, 1.013%]) (Figure 2; Supplementary Table S1). The city-specific RRs varied among cities, ranging from 1.001 (95%CI= [0.995, 1.008]) in Guatemala City to 1.018 (95%CI= [1.009, 1.028]) in Montevideo for PM10 and from 1.008 (95%CI= [1.004, 1.012]) in Santiago to 1.021 (95%CI= [1.008, 1.035]) in Montevideo for PM2.5.

Figure 2
www.frontiersin.org

Figure 2. Pooled and city-specific short-term association of mortality with 2-day moving average concentration of particulate matter, as relative risk (RR, and 95% confidence interval) for a 10 μg/m3 increase (Latin America, 2009–2018). Note: PM10: Particulate matter with an aerodynamic diameter of 10 μm or less. PM2.5: Particulate matter with an aerodynamic diameter of 2.5 μm or less. *Cities with only PM10 data available.

Overall, PM10 and PM2.5 were found to be associated with an excess mortality of 1.88% (95% eCI = [1.02, 2.76]) and 1.05% (95% eCI = [0.42, 1.70]) with levels above the WHO AQGs limit values, respectively (Figure 3; Supplementary Table S2). For PM10, city-specific excess mortality ranged from 0.39% (95%eCI = [−1.30, 2.13]) in Guatemala to 2.62% (95%eCI = [−0.17, 5.46]) in Quito, while for PM2.5, city-specific excess mortality ranged from 0.42% (95%eCI = [0.08, 0.76]) in Sao Paulo to 2.13% (95%eCI = [−0.99, 5.29]) in Quito. It should be noted that the estimates in Bogota, Guatemala City, and Quito exhibit some uncertainties.

Figure 3
www.frontiersin.org

Figure 3. Pooled and city-specific excess mortality associated with particulate matter concentrations above the World Health Organization air quality guidelines limit (Latin America, 2009–2018). Note: The World Health Organization air quality guidelines limit values are 15 μg/m3 for particulate matter with an aerodynamic diameter of 10 μm or less (PM10) and 5 μg/m3 for particulate matter with an aerodynamic diameter of 2.5 μm or less (PM2.5). *Cities with only PM10 data available.

Table 2 shows the city-specific annual average estimates on excess deaths and economic cost associated with PM concentrations above the WHO AQGs limit values. The annual average economic costs of PM10 varied widely from US $19.5 million (95%eCI = [−64.4, 105.4]) in Guatemala City to US$ 3,386.9 million (95%eCI = [2,728.7, 4,076.2]) in Sao Paulo. Similarly, for PM2.5, costs ranged from US$ 196.3 million (95%eCI = [−91.7, 488.8]) in Quito to US$ 2,209.6 million (95%eCI = [1,072.3, 3,396.1]) in Mexico City. Notably, Mexico City, Santiago, and Sao Paulo showed the heaviest economic burden, exceeding both PM10 and PM2.5 WHO AGQs limit values.

Table 2
www.frontiersin.org

Table 2. City-specific average annual excess deaths and annual economic cost associated with particulate matter concentrations above the World Health Organization air quality guidelines limit (Latin America, 2009–2018).

Discussion

This study analyzes data on PM and daily mortality in nine major cities in Latin America, providing evidence of the health and economic impact of daily PM concentrations above the WHO AQGs recently updated limit values for PM10 and PM2.5.

In the analysis, we observed a risk increase of 0.7% in all-cause mortality per 10 μg/m3 increase in PM10 and 1% for PM2.5. These risk estimates are similar to those reported in previous studies in Latin American countries. The ESCALA study reported a mortality risk of 0.77% for PM10 [13], while a systematic review estimated a pooled mortality risk of 1% for PM2.5 [2]. However, the short-term effects of PM in Latin America are somewhat larger than those described in studies at the global scale. For example, Liu et al. [9] reported risk increases of 0.44% and 0.68% for PM10 and PM2.5, respectively, in a study from 652 cities in 24 countries. Similarly, a WHO systematic review reported risk increases of 0.41% for PM10 and 0.65% for PM2.5 [3]. However, the city-specific risk estimates showed geographical variability, ranging between 0.1% and 1.8% for a 10 μg/m3 increase of PM10, and 0.8% to 2.1% for PM2.5. These may be related to city-specific demographics, such as variations in age distribution, socio-economic development, PM sources, and climate conditions. However, further studies are warranted to investigate these variations.

Nevertheless, our study offers a new perspective on the impact of short-term exposure to PM pollution in Latin America by estimating the health burden and its economic consequences at the city level, an investigation lacking in previous studies. In most cities studied, PM concentration exceeded WHO AQGs limit values on over 90% of days. In several cities, daily average PM10 and PM2.5 concentration consistently surpassed WHO AQG limit values.

In addition, PM10 and PM2.5 are associated with a short-term excess mortality of 0.39% and 0.43%, respectively, with levels above the current WHO AQGs limit values. This implies an estimated annual economic cost, which varies widely between US $19.5 to 3386.9 million for PM10, and US $196 to 2209.6 million for PM2.5. However, comparisons with previous studies are not straightforward since previous studies estimating deaths attributable to ambient PM mainly focused on the long-term effects, which are much larger than our estimation of the short-term effects. A regional multi-city study including 366 Latin American cities revealed that 58% of the population lived in the areas where annual PM2.5 concentrations surpassed the 2005 WHO AQG of 10 μg/m3 [14]. Moreover, the State of Global Air estimated the number of deaths attributable to long-term exposure to PM2.5 in the Latin American countries considered in our study ranged between 733 in Uruguay to 43,600 in Brazil [15]. Similarly, different methods have been used to estimate economic impact. For example, Trejo-González et al. [16] estimated that an average reduction of 10 μg/m3 in the annual PM2.5 in fifteen cities in Mexico during 2015 would have prevented 14,666 deaths and 150,771 potential years of life lost in 2015, with estimated costs of US $64,164 and $5,434 million, respectively. A recent study reported US$ 148.3 billion could be attributed to productivity lost due to PM2.5 above the 2021 WHO AQGs in Brazil between 2000 and 2019 [17]. Moreover, Bell et al. [18] estimated the economic benefits of PM pollution reduction under two emission scenarios in Mexico City, Santiago, and Sao Paulo using willingness-to-pay and cost-of-illness from 2000 to 2020 for two emission scenarios based on current emissions patterns and regulatory trends and a control policy aimed at lowering air pollution, which was roughly US $21 to $165 billion.

Despite methodological disparities, our findings, coupled with previous studies, underline the substantial health burden and the associated economic cost posed by air pollution in Latin American urban centers, underscoring the significant benefits of lowering the PM concentrations to the current WHO AQGs limit values [6]. However, the urbanization process continues to increase in Latin American countries [1]. The primary factors leading to the deteriorating air quality in the region are the vehicle fleet, industrial sources, and biomass burning [14]. The combustion of solid fuels for cooking or heating within households adds to the overall air pollution in urban areas of certain countries, particularly where a significant portion of the population relies on solid fuels as their primary energy source [1]. These may lead governments to consider that updating their national ambient air quality standards to achieve the newly updated WHO AGQs limit values may not be feasible in their local context at the short term. Here, the interim targets proposed by WHO may be useful steps toward a progressive reduction of PM concentrations [5].

It is necessary for the countries in the region to update the regulatory framework for air quality, especially for PM, to protect public health and the environment. This should include sustainable solutions for public transportation and mobility, as well as the promotion of sustainable clean energy [1]. In this context, countries like Mexico, Colombia, and Brazil have approached their air quality standards to the WHO guidelines. However, the regulatory framework should also include the emission standards, which have a considerable delay for the countries in the region, as well as regulations related to the specifications of the fuels used.

Several limitations should be acknowledged. Single-pollutant models were fitted because data for gaseous pollutants (i.e., nitrogen and sulfur dioxides) were unavailable. In a global study, Liu et al. [9] found that the magnitude of the PM10 and PM2.5 associations with all-cause mortality, although they remained statistically significant, decreased after adjusting for gaseous pollutants. Moreover, we used time-series analysis to derive the concentration-response associations of short-term exposure to PM. It is important to note that this approach may lead to an underestimation of the potential health and economic impact associated with reducing PM concentrations. Time-series studies capture only cases in which death has been triggered by air pollution exposure incurred shortly before death [19]. For instance, we observed a risk of 1% in all-cause mortality per 10 μg/m3 increase in PM2.5 which is notably smaller compared to the 9% estimated for the long-term exposure [20]. Furthermore, the short-term effect of PM on all-cause mortality is merely the tip of the iceberg, ignoring numerous other acute health outcomes and diseases, such as myocardial infarctions and cardiorespiratory acute hospitalizations, that are also linked to PM exposure. Therefore, we recommend future studies include other acute health outcomes and extend the current analysis to assess the long-term effects of air quality improvement related to PM in Latin America.

In conclusion, the findings reported in this study show noteworthy evidence that there is an urgent need for policymakers to develop more ambitious policies aimed at achieving sustainable air quality improvements in Latin America. Complying with the WHO AQGs daily limit values for PM10 and PM2.5 would provide substantial benefits for the urban populations in Latin American cities.

Author Contributions

AT and LM conceptualized the study and directed the study’s implementation. JA conducted the data curation and statistical analysis with substantial contribution from LM and AT. LAC, HR-R, MHD, MdSZSC, RA, SO, GCE, NVO, VC, and DR contributed to the acquisition and interpretation of data. LM, JA, and AT drafted the manuscript with substantial contributions from LAC, HR-R, MHD, MdSZSC, RA, SO, GCE, NVO, VC, and DR. All authors contributed to the article and approved the submitted version.

Funding

The author(s) declare that financial support was received for the research, authorship, and/or publication of this article. AT was supported by the Japanese Society for the Promotion of Science (JSPS) Invitational Fellowships for Research in Japan (grant S22077).

Conflict of Interest

The authors declare that they do not have any conflicts of interest.

Acknowledgments

We thank the Editor and reviewers for their valuable comments and useful suggestions on the manuscript.

Supplementary Material

The Supplementary Material for this article can be found online at: https://www.ssph-journal.org/articles/10.3389/ijph.2024.1606909/full#supplementary-material

References

1. Riojas-Rodriguez, H, da Silva, AS, Texcalac-Sangrador, JL, and Moreno-Banda, GL. Air Pollution Management and Control in Latin America and the Caribbean: Implications for Climate Change. Rev Panam Salud Publica (2016) 40(3):150–9.

PubMed Abstract | Google Scholar

2. Fajersztajn, L, Saldiva, P, Pereira, LAA, Leite, VF, and Buehler, AM. Short-Term Effects of Fine Particulate Matter Pollution on Daily Health Events in Latin America: A Systematic Review and Meta-Analysis. Int J Public Health (2017) 62(7):729–38. doi:10.1007/s00038-017-0960-y

PubMed Abstract | CrossRef Full Text | Google Scholar

3. Orellano, P, Reynoso, J, Quaranta, N, Bardach, A, and Ciapponi, A. Short-Term Exposure to Particulate Matter (PM(10) and PM(2.5)), Nitrogen Dioxide (NO(2)), and Ozone (O(3)) and All-Cause and Cause-Specific Mortality: Systematic Review and Meta-Analysis. Environ Int (2020) 142:105876. doi:10.1016/j.envint.2020.105876

PubMed Abstract | CrossRef Full Text | Google Scholar

4. WHO Regional Office for Europe. Health Risks of Air Pollution in Europe-HRAPIE Project: Recommendations for Concentration-Response Functions for Cost–Benefit Analysis of Particulate Matter, Ozone and Nitrogen Dioxide. Copenhagen: World Health Organization (2013). Available from: http://www.euro.who.int/en/health-topics/environment-and-health/air-quality/publications/2013/health-risks-of-air-pollution-in-europe-hrapie-project-recommendations-for-concentrationresponse-functions-for-costbenefit-analysis-of-particulate-matter,-ozone-and-nitrogen-dioxide (Accessed February 21, 2024).

Google Scholar

5. World Health Orgnization. WHO Global Air Quality Guidelines: Particulate Matter (PM2.5 and PM10), Ozone, Nitrogen Dioxide, Sulfur Dioxide and Carbon Monoxide. Geneva: World Health Organization (2021).

Google Scholar

6. Hoffmann, B, Boogaard, H, de Nazelle, A, Andersen, ZJ, Abramson, M, Brauer, M, et al. WHO Air Quality Guidelines 2021-Aiming for Healthier Air for All: A Joint Statement by Medical, Public Health, Scientific Societies and Patient Representative Organisations. Int J Public Health (2021) 66:1604465. doi:10.3389/ijph.2021.1604465

PubMed Abstract | CrossRef Full Text | Google Scholar

7. OECD. The Economic Consequences of Outdoor Air Pollution. Paris: OECD Publishing (2016).

Google Scholar

8. Bhaskaran, K, Gasparrini, A, Hajat, S, Smeeth, L, and Armstrong, B. Time Series Regression Studies in Environmental Epidemiology. Int J Epidemiol (2013) 42(4):1187–95. doi:10.1093/ije/dyt092

PubMed Abstract | CrossRef Full Text | Google Scholar

9. Liu, C, Chen, R, Sera, F, Vicedo-Cabrera, AM, Guo, Y, Tong, S, et al. Ambient Particulate Air Pollution and Daily Mortality in 652 Cities. N Engl J Med (2019) 381(8):705–15. doi:10.1056/NEJMoa1817364

PubMed Abstract | CrossRef Full Text | Google Scholar

10. Adebayo-Ojo, TC, Wichmann, J, Arowosegbe, OO, Probst-Hensch, N, Schindler, C, and Künzli, N. A New Global Air Quality Health Index Based on the WHO Air Quality Guideline Values With Application in Cape Town. Int J Public Health (2023) 68:1606349. doi:10.3389/ijph.2023.1606349

PubMed Abstract | CrossRef Full Text | Google Scholar

11. Gasparrini, A, and Leone, M. Attributable Risk From Distributed Lag Models. BMC Med Res Methodol (2014) 14:55. doi:10.1186/1471-2288-14-55

PubMed Abstract | CrossRef Full Text | Google Scholar

12. Viscusi, WK, and Masterman, CJ. Income Elasticities and Global Values of a Statistical Life. J Benefit-Cost Anal (2017) 8(2):226–50. doi:10.1017/bca.2017.12

CrossRef Full Text | Google Scholar

13. Romieu, I, Gouveia, N, Cifuentes, LA, de Leon, AP, Junger, W, Vera, J, et al. Multicity Study of Air Pollution and Mortality in Latin America (The ESCALA Study). Res Rep Health Eff Inst (2012) 171(171):5–86.

PubMed Abstract | Google Scholar

14. Gouveia, N, Kephart, JL, Dronova, I, McClure, L, Granados, JT, Betancourt, RM, et al. Ambient Fine Particulate Matter in Latin American Cities: Levels, Population Exposure, and Associated Urban Factors. Sci Total Environ (2021) 772:145035. doi:10.1016/j.scitotenv.2021.145035

PubMed Abstract | CrossRef Full Text | Google Scholar

15. Health Effects Institute. State of Global Air 2020. Special Report. Boston, MA: Health Effects Institute (2020).

Google Scholar

16. Trejo-González, AG, Riojas-Rodriguez, H, Texcalac-Sangrador, JL, Guerrero-López, JL, Cervantes-Martínez, K, Hurtado-Diaz, M, et al. Quantifying Health Impacts and Economic Costs of PM2.5 Exposure in Mexican Cities of the National Urban System. Int J Public Health (2019) 64(4):561–72. doi:10.1007/s00038-019-01216-1

PubMed Abstract | CrossRef Full Text | Google Scholar

17. Wen, B, Ademi, Z, Wu, Y, Xu, R, Yu, P, Ye, T, et al. Ambient PM2.5 and Productivity-Adjusted Life Years Lost in Brazil: A National Population-Based Study. J Haz Mat (2024) 467:133676. doi:10.1016/j.jhazmat.2024.133676

CrossRef Full Text | Google Scholar

18. Bell, ML, Davis, DL, Gouveia, N, Borja-Aburto, VH, and Cifuentes, LA. The Avoidable Health Effects of Air Pollution in Three Latin American Cities: Santiago, Sao Paulo, and Mexico City. Environ Res (2006) 100(3):431–40. doi:10.1016/j.envres.2005.08.002

PubMed Abstract | CrossRef Full Text | Google Scholar

19. Kunzli, N, Medina, S, Kaiser, R, Quenel, P, Horak, F, and Studnicka, M. Assessment of Deaths Attributable to Air Pollution: Should We Use Risk Estimates Based on Time Series or on Cohort Studies? Am J Epidemiol (2001) 153(11):1050–5. doi:10.1093/aje/153.11.1050

PubMed Abstract | CrossRef Full Text | Google Scholar

20. Pope, CA, Coleman, N, Pond, ZA, and Burnett, RT. Fine Particulate Air Pollution and Human Mortality: 25+ Years of Cohort Studies. Environ Res (2020) 183:108924. doi:10.1016/j.envres.2019.108924

PubMed Abstract | CrossRef Full Text | Google Scholar

Keywords: air pollution, particulate matter, mortality, Latin America, air quality regulation, economic benefits

Citation: Madaniyazi L, Alpízar J, Cifuentes LA, Riojas-Rodríguez H, Hurtado Díaz M, de Sousa Zanotti Stagliorio Coelho M, Abrutzky R, Osorio S, Carrasco Escobar G, Valdés Ortega N, Colistro V, Roye D and Tobías A (2024) Health and Economic Benefits of Complying With the World Health Organization Air Quality Guidelines for Particulate Matter in Nine Major Latin American Cities. Int J Public Health 69:1606909. doi: 10.3389/ijph.2024.1606909

Received: 29 November 2023; Accepted: 08 May 2024;
Published: 30 May 2024.

Edited by:

Nino Kuenzli, Swiss Tropical and Public Health Institute (Swiss TPH), Switzerland

Reviewed by:

Bing Han, China Medical University, China
One reviewer who chose to remain anonymous

Copyright © 2024 Madaniyazi, Alpízar, Cifuentes, Riojas-Rodríguez, Hurtado Díaz, de Sousa Zanotti Stagliorio Coelho, Abrutzky, Osorio, Carrasco Escobar, Valdés Ortega, Colistro, Roye and Tobías. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Lina Madaniyazi, lina.madaniyazi@nagasaki-u.ac.jp

Present address:
Dominic Roye, Climate Research Foundation (FIC), Madrid, Spain

These authors share first authorship

This Original Article is part of the IJPH Special Issue “Science to Foster the WHO Air Quality Guideline Values”

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.